PHRM 3310 Test 2

0.0(0)
Studied by 5 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/320

flashcard set

Earn XP

Description and Tags

Drug Development & Lifecycle; Toxicology, Pharmacology, & Special Patient Populations; Herbal Drugs; Autonomic Pharmacology

Last updated 4:30 PM on 10/12/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

321 Terms

1
New cards

What are the MAIN sequential stages of the drug developmental process?

Discovery & Development → Preclinical Research → Clinical Development → Regulatory Review → Post-Market Surveillance

2
New cards

What is the fundamental purpose of discovering new drugs?

to develop safe, effective drugs that fill a therapeutic need

3
New cards

Who discovers drugs?

  • government labs

  • pharmaceutical companies

  • public & private university research centers


4
New cards

Through what methods/approaches do scientists discover drugs?

  • new drug targets: basic science, disease mechanisms

  • rational drug design: molecular modeling

  • structure/activity: medicinal chemistry

  • screening: natural products, chemical libraries, high-throughput assays (to find drug candidates w/ highest efficacy & lowest toxicity)


5
New cards

What is the timeline & cost from drug discovery to U.S. market approval?

10+ years (12-14 years average) & $>100,000,000 per successful drug

6
New cards

What is the value of the worldwide annual pharmaceutical market?

$1.6 trillion

7
New cards

What are the 2 distinct pathways for drug discovery?

  • (1) rational drug design

    • disease → mechanism → target → structure → lead compound → refine

  • (2) screening

    • disease → model of disease → huge chemical diversity → lead compound → mechanism → refine


8
New cards

What are the optimization techniques?

  • efficacy

  • toxicity

  • dosage form

  • A.D.M.E.


9
New cards

What biological/pharmaceutical disciplines contribute to drug discovery?

  • cell biology

  • biochemistry

  • genetics

  • physiology

  • pharmacology

  • pharmaceutics

  • medicinal chemistry


10
New cards

What are the KEY steps in the drug discovery workflow?

  • (1) choose target (e.g., enzyme)

    • know the mechanism

  • (2) choose system: simple assay (e.g., cell lines)

    • work up: In vitro, cells, animals

  • (3) determine specificity: off-target effects

  • (4) identify “hits”


11
New cards

Why is it critical to choose a good animal model?

  • predict toxicity/side effects

  • identify lead compounds

  • optimize lead compounds


12
New cards

What tools & methodologies are used during the DRUG DISCOVERY (0-5+ years) stage of the U.S. Drug Development Process?

  • combinatorial chemistry

  • natural product isolation

  • QSAR (qualitative structure activity relationship)

  • pharmacology

  • biology

  • In vitro

  • future: In vivo & ADME


13
New cards

What tools & methodologies are used during the PRECLINICAL (1-3+ years) stage of the U.S. Drug Development Process?

  • synthesis

  • pre/formulation

  • development

  • pharmacokinetics

  • animal testing

  • stability


14
New cards

What are the MAIN causes of drug failure during development & their percentage rates?

  • pharmacokinetics (39%)

  • lack of efficacy (30%)

  • animal toxicity (11%)

  • commercial reasons (11%)

  • adverse effects in people (10%)

  • miscellaneous (5%)


15
New cards

Why is it important to fail early in drug development?

failing early minimizes financial loss from expensive late-stage R&D + clinical trials

16
New cards

What role does the Food & Drug Administration (FDA) play in drug development?

  • regulates BOTH development & marketing

  • safety & efficacy

  • pre-clinical & clinical testing requirements


17
New cards

What are the primary preclinical requirements BEFORE clinical (human) trials?

*stringency influenced by urgency & proposed use*

  • toxicity studies in animals

  • demonstration of efficacy in animals (where applicable)

  • pharmacokinetic studies

  • mechanism


18
New cards

How many years can the CLINICAL stage of the U.S. Drug Development Process take?

3-8+ years

19
New cards

What specific types of toxicity are tested during preclinical animal studies?

  • acute: lethal dose

  • subacute: proposed dose & course of treatment

  • chronic: proposed dose for longer time course


20
New cards

What specific general safety measures are tested during preclinical animal studies?

  • pharmacological profile: blood pressure, GI activity, renal function

  • reproductive toxicity: teratogenesis, mutagenesis

  • carcinogenesis: malignancy


21
New cards

What limitations exist in preclinical testing?

  • time & money

    • 2-5 years before being administered to humans

    • $41,000,000 per successful drug

  • animal welfare

    • heavy concerns

  • humans do NOT equal animals

    • special differences


22
New cards

What is an IND?

it is an Investigational New Drug application

23
New cards

When is an IND filed?

it is filed after successful preclinical testing & BEFORE human clinical trials start (“first in man”)

24
New cards

What does an IND contain?

it contains…

  • composition & sources of drug, manufacturing information

  • animal studies

  • clinical plans/protocols with physicians’ credentials


25
New cards

What defines Phase I clinical trials?

  • focuses on SAFETY & pharmacokinetics in humans

    • usually “open”

    • uses 20-30 participants who are usually healthy (except in chemotherapy trials)


26
New cards

What defines Phase II clinical trials?

  • focuses on EFFICACY (limited efficacy study) & side effects

    • usually single-blind

    • uses 100-300 patients WITH the disease

    • placebo controls


27
New cards

What defines Phase III clinical trials?

  • focuses on POPULATION (BOTH expanded SAFETY & EFFICACY)

    • usually double-blind

    • uses 1,000-5,000 patients across multiple locations

    • compares drug to placebo OR existing therapy

    • toxicity screening


28
New cards

What are the primary limitations & biases in clinical trials?

  • rare effects will NOT likely be detected

  • positive controls (existing drug on the market) & negative controls (placebo)

    • patients with terminal illnesses (late-stage cancer)

  • interference by medical history or subjects

    • screening (full disclosure)

    • legitimate randomization

  • bias

    • placebo effect (20-40%)

    • placebo NOT used in terminal or severe illness

    • subject bias addressed w/ single-blind design

    • subject + observer bias addressed w/ double-bind design


29
New cards

What is an NDA?

it is a New Drug Application

30
New cards

When is an NDA submitted?

it is submitted to the FDA after successfully passing Phase III clinical trials to request permission to market the drug (“to market”)

31
New cards

What does an NDA contain?

contains all clinical & preclinical data

32
New cards

How long does it take for an NDA to be reviewed?

it may take several years to review

33
New cards

What defines Phase IV (Post-Marketing Surveillance)?

  • monitors long-term safety, efficacy, & low-incidence toxicities/side effects (e.g., 1:10,000) that ONLY appear AFTER wide marketing

  • checks for new indications

  • not as tightly regulated


34
New cards

When do generic drugs appear on the market?

they appear 20 years after patent application, or up to 14 years after NDA approval if an extension was granted due to approval delays

35
New cards

What are PREDICTED adverse reactions?

they are toxicity related to known pharmacological mechanism or identified off-target effects

36
New cards

What are UNEXPECTED adverse reactions?

  • they are unidentified off-target effects or allergic reactions

    • IgE-mediated: anaphylaxis, urticaria, angioedema

    • IgG/IgM-mediated: lupus, serum sickness, contact dermatits


37
New cards

What is the primary purpose of Phase II clinical trials?

to evaluate efficacy & side effects in a small group of patients

38
New cards

During which phase are large-scale, controlled clinical trials conducted to confirm effectiveness & monitor side effects of a drug?

Phase III

39
New cards

What document must be filed with the FDA after successful preclinical testing & before starting human clinical trials?

Investigational New Drug (IND) Application

40
New cards

Which of the following best describes “Phase IV” of the drug approval process?

post-marketing surveillance to monitor safety & efficacy

41
New cards

A drug company submits a(n) ____ to the FDA to ask for approval to market a new drug after completing Phases I-III?

New Drug Application (NDA)

42
New cards

Which statement best describes toxicology as a scientific discipline?

it is arguably the oldest scientific discipline, since early humans had to recognize which plants were safe to eat

43
New cards

Most human exposure to chemicals occurs through…

naturally occurring compounds consumed from food plants

44
New cards

Humans are exposed to chemicals…

BOTH inadvertently & deliberately

45
New cards

Toxicology is best defined as the study of…

toxic or drug-related adverse effects of drugs or chemicals on the health of living systems

46
New cards

Who is considered the father of modern toxicology?

Paracelsus

47
New cards

The statement “the dose makes the poison” means…

ANY chemical or drug can be toxic if given at a high enough dose

48
New cards

A toxicologist is trained to…

examine the nature of adverse effects & assess the probability of their occurrence

49
New cards

Toxicogenomics is used to…

identify & protect genetically susceptible individuals from harmful environmental exposures and to customize drug therapies based on individual genetic makeup

50
New cards

Which of the following is NOT a MAJOR category of toxic exposure?

dietary supplements

51
New cards

Which of the following is a route of EXPOSURE?

all

52
New cards

The spectrum of toxic effects includes ALL of the following EXCEPT…

acute vs. chronic potency

53
New cards

Animal testing for drug toxicity must be approved by which committee?

the Institute Animal Ethics Committee (IAEC)

54
New cards

Researchers are trying to minimize animal testing using alternative methods such as…

in vitro & in silico studies

55
New cards

Why are researchers seeking to minimize animal testing?

because of expensive & complex protocols and the difficulty of extrapolating data to humans

56
New cards

LD50 is defined as…

the dose that is LETHAL to 50% of the population

57
New cards

When comparing toxicants using LD50, the most potent (lethal) compound is the one with…

the LOWEST LD50 value

58
New cards

Exposure to a chemical for < 24 hours is classified as…

acute

59
New cards

Repeated exposure to a chemical for 1 month or less is classified as…

subacute

60
New cards

Repeated exposure to a chemical for 1-3 months is classified as…

sub-chronic

61
New cards

Repeated exposure to a chemical for > 3 months is classified as…

chronic

62
New cards

The main goal of toxicology studies during drug development is to…

provide a PRE-liminary safety level of drug candidates from SEVERAL routes of exposure

63
New cards

Which of the following is a question addressed during animal PRE-clinical testing?

all

64
New cards

In human clinical testing, safety studies in a SMALL number of patients occur in…

Phase I

65
New cards

Post-marketing surveillance occurs in…

Phase IV

66
New cards

Safety monitoring in THOUSANDS of patients occurs in…

Phase III

67
New cards

Which phase involves healthy volunteers vs. patients?

Phase I

68
New cards

Which of the following is an observation made in animal toxicity studies?

body weight, feed/water intake, appearance, & activity levels

69
New cards

Hepatocellular evaluation in clinical testing uses which markers?

alanine aminotransferase (ALT) & aspartate aminotransferase (AST)

70
New cards

Hepatobiliary evaluation uses which markers?

alkaline phosphatase & total bilirubin

71
New cards

Which if the following is measured as part of clinical toxicity testing?

all

72
New cards

In the study of 150 compounds, what was the concordance between rodent & human target organs?

43%

73
New cards

In the study of 150 compounds, what was the concordance between NON-rodent & human target organs?

63%

74
New cards

Overall, in the study of 150 compounds, what concordance was observed between animal special & humans for the SAME organ toxicity?

70%

75
New cards

In the study of 150 compounds, the 70% overall concordance between animals & humans was specifically for which toxicities?

cardiovascular (CV), GI, & hematological

76
New cards

The “3 Rs” in animal research refer to…

reduction, refinement, & replacement

77
New cards

Why are laboratory animals STILL needed?

NO real substitutes exist; the complexity of living organisms requires testing on animals “similar to” humans for reliable, effective results

78
New cards

Which of the following is a developmental population requiring special consideration?

all

79
New cards

Which factor affects a drug’s access to the placenta?

all

80
New cards

Regarding lipid solubility & placental transfer,…

NON-ionized compounds reach the placenta at HIGH concentrations

81
New cards

Regarding molecular size & placental transfer,…

compounds <500 Da cross easily, but compounds >1000 Da cross VERY slowly

82
New cards

Why is heparin a safe anticoagulant for pregnant women while heparin is NOT?

heparin is BIG & POLAR, so it does NOT cross the placenta; warfarin CAN cross

83
New cards

The MDR1 transporter in the placenta…

pumps many drugs BACK to the mother & its effect depends on expression level

84
New cards

The placenta is capable of which types of metabolic reactions?

BOTH Phase I (oxidation, reduction, hydrolysis) & Phase II (conjugation) reactions

85
New cards

Why does MOST fetal blood enter the liver directly?

for detoxification

86
New cards

Which drugs are delivered to the mother to target the fetus therapeutically?

BOTH corticosteroids (to induce lung development) & zidovudine (to minimize HIV transmission)

87
New cards

A teratogenic drug…

disturbs the development of the embryo or fetus & can affect oxygen or nutrient availability

88
New cards

Characteristics of teratogens include ALL of the following EXCEPT…

they affect ALL stages of development EQUALLY

89
New cards

Regarding counseling about drug use in pregnancy,…

all

90
New cards

What is Pregnancy Category D?

there is POSITIVE evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, BUT potential benefits MAY warrant use of the drug in pregnant women DESPITE potential risks

91
New cards

What is Pregnancy Category X?

studies in animals or humans have demonstrated fetal abnormalities and/or there is POSITIVE evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, & the risks involved in use of the drug in pregnant women clearly OUTWEIGH potential benefits

92
New cards

Which of the following affects drug absorption in INFANTS?

all

93
New cards

Compared to adults, INFANTS have…

HIGHER relative water volume & less fat, affecting lipophilic drug distribution

94
New cards

INFANTS have LOWER plasma protein binding, which results in…

HIGHER available (free) drug concentration, requiring careful dosing

95
New cards

NEONATES have LOWER liver metabolic enzyme levels, resulting in…

LONGER half-life

96
New cards

Regarding drug excretion in INFANTS,…

GFR is VERY low for the 1st week of a full-term baby & normal BY 1 year

97
New cards

Which drugs are cleared VERY slowly in NEONATES?

penicillin & aminoglycoside antibiotics

98
New cards

They KEY takeaway about dosing INFANTS & CHILDREN is that they…

canNOT be considered SMALLER versions of adults when giving them drugs

99
New cards

Regarding drug use during breastfeeding,…

MOST drugs are safe while breastfeeding & breastfeeding is BEST for the baby

100
New cards

What is the SAFEST time to take a drug relative to feeding?

3 hours PRIOR to feeding